Background and aims: Motor fluctuations are a major challenge in advanced Parkinson's disease (PD), often managed using add‐on therapies such as catechol‐O‐methyl transferase (COMT) or monoamine oxidase‐B (MAO‐B) inhibitors. The gene discussed is COMT; the disease is Parkinson disease.